Patent Assignment
Reel/Frame 071564/0463
U.S. Patent Security Agreement
Recorded: 2025-06-13
Pages: 20
Assignors
MEDICIS PHARMACEUTICAL CORPORATION
Executed: 2025-04-08
ORAPHARMA, INC.
Executed: 2025-04-08
BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC)
Executed: 2025-04-08
PRECISION DERMATOLOGY, INC.
Executed: 2025-04-08
SALIX PHARMACEUTICALS, INC.
Executed: 2025-04-08
SANTARUS, INC.
Executed: 2025-04-08
BAUSCH HEALTH AMERICAS, INC.
Executed: 2025-04-08
SOLTA MEDICAL, INC.
Executed: 2025-04-08
Assignee
THE BANK OF NEW YORK MELLON
240 GREENWICH STREET, FLOOR 7E, ATTN: CORPORATE TRUST ADMINISTRATION, NEW YORK, NEW YORK, 10286
Covered Properties
(149)
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Adaptive Control of Optical Pulses for Laser Medicine
Colonic Purgative Composition with Soluble Binding Agent
Ultrasound Therapy Head with Movement Control
Apparatus and Method to Apply Substances to Tissue
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Method for the Treatment of Acne
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Methods and apparatus for coupling a HIFU transducer to a skin surface
Apparatus and Methods for the Destruction of Adipose Tissue
Treatment Apparatus and Methods for Delivering Energy at Multiple Selectable Depths in Tissue
Electrode Assembly and Handpiece with Adjustable System Impedance, and Methods of Operating an Energy-Based Medical System to Treat Tissue
Laser-induced transepidermal elimination of content by fractional photothermolysis
Articulated Arm for Delivering a Laser Beam
Optical System Having Aberrations for Transforming a Gaussian Laser-Beam Intensity Profile to a Quasi-Flat-Topped Intensity Profile in a Focal Region of the Optical System
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Minocycline Oral Dosage Forms for the Treatment of Acne
Minocycline Oral Dosage Forms for the Treatment of Acne
Minocycline Oral Dosage Forms for the Treatment of Acne
Apparatus and Method for Adjustable Fractional Optical Dermatological Treatment
Apparatus and Method for Adjustable Fractional Optical Dermatological Treatment
Substituted Arylamino -1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Amorphous Form of Rifaximin and Processes for Its Preparation
Pivoting Roller Tip for Dermatological Treatment Apparatus
Method and apparatus for monitoring and controlling laser-induced tissue treatment
Slip Ring Spacer and Method for Its Use
Colonic Purgative Composition with Soluble Binding Agent
Treatment of Alopecia by Micropore Delivery of Stem Cells
Optical Pattern Generator Using a Single Rotating Optical Component with Ray-Symmetry-Induced Image Stability
Method for Reducing Pain of Dermatological Treatments
Treatment Apparatus and Methods for Delivering High Frequency Energy Across Large Tissue Areas
Rifaximin Anti-Rectal Dysfunction Preparation
Adaptive Control of Optical Pulses for Laser Medicine
Minocycline Oral Dosage Forms for the Treatment of Acne
Reconnectable Handpieces for Optical Energy Based Devices and Methods for Adjusting Device Components
Device for Delivering Medicinal Implants
Medicinal Implant Cartridge
Actuators for Device for Delivering Medicinal Implants
Optical Pattern Generators Using Axicon Segments
Therapy Head for Use with an Ultrasound System
Forms of Rifaximin and Uses Thereof
Methods for Treating Diarrhea-Associated Irritable Bowel Syndrome
Method for the Treatment of Acne and Certain Dosage Forms Thereof
Apparatus and Methods for the Destruction of Adipose Tissue
Medicinal Implant Device and Cartridge
Tissue Treatment Apparatus with Functional Mechanical Stimulation and Methods for Reducing Pain During Tissue Treatments
Tissue Treatment Apparatus and Systems with Pain Mitigation and Methods for Mitigating Pain During Tissue Treatments
Forms of Rifaximin and Uses Thereof
Ultrasonic Treatment of Adipose Tissue at Multiple Depths
Analysis of Real Time Backscatter Data for Fault Signal Generation in a Medical Hifu Device
Transducer Cartridge for an Ultrasound Therapy Head
Cartridge for Use with an Ultrasound Therapy Head
Liquid Degas System
Medical Ultrasound Device with Liquid Dispensing Device Coupled to a Therapy Head
Tissue Treatment Systems with High Powered Functional Electrical Stimulation and Methods for Reducing Pain During Tissue Treatments
Stabilized Steroid Composition and Method for its Preparation
Extended-Release Minocycline Dosage Forms
Patent:
8,722,650 →
Application:
12/861,424 →
Pump Systems and Methods for Storing and Dispensing a Plurality of Precisely Measured Unit-Doses of Imiquimod Cream
Minocycline Oral Dosage Forms for the Treatment of Acne
Selective Lysing of Cells Using Ultrasound
Apparatus and Method for Adjustable Fractional Optical Dermatological Treatment
Apparatus and Method for Adjustable Fractional Optical Dermatological Treatment
Methods of Treating Travelers Diarrhea and Hepatic Encephalopathy
Handpiece for Ultrasonic Medical Devices Including Seal for Mechanical Isolation of Ultrasonic Driver Assembly
Handheld Apparatus for Use by a Non-Physician Consumer to Fractionally Resurface the Skin of the Consumer
High Oil-Content Emollient Aerosol Foam Compositions
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Forms of Rifaximin and Uses Thereof
Device for Delivering Medicinal Implants
2 X 2 X 2 Week Treatment Regimen for Treating Actinic Keratosis with Pharmaceutical Compositions Formulated with 2.5% Imiquimod
2 X 2 X 2 Week Dosing Regimen for Treating Actinic Keratosis with Pharmaceutical Compositions Formulated with 3.75 % Imiquimod
Method of Treating Actinic Keratosis with 3.75% Imiquimod Cream
Cooled Medical Handpiece
Modified Atmosphere Packaging for Ultrasound Transducer Cartridge
Power Assisted Lipoplasty
Forms of Rifaximin and Uses Thereof
Method and Apparatus for Breath Testing
Forms of Rifaximin and Uses Thereof
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Forms of Rifaximin and Uses Thereof
Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis with Shorter Durations of Imiquimod Therapy
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
2 X 2 X 2 Week Dosing Regimen for Treating Actinic Keratosis with Pharmaceutical Compositions Formulated with 3.75 % Imiquimod
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Combination Therapy with Low Dosage Strength Imiquimod and Photodynamic Therapy to Treat Actinic Keratosis
Forms of Rifaximin and Uses Thereof
Ultrasonic Probe for Treating Cellulite
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Apparatus and Methods for the Destruction of Adipose Tissue
Ultrasonic Transducer
Patterned Electrodes for Tissue Treatment Systems
Methods of Treating Hepatic Encephalopathy
Methods for Treating Irritable Bowel Syndrome (Ibs)
Antibody Formulations
Methods of Treating Hepatic Encephalopathy
Transducer Cartridge for an Ultrasound Therapy Head
Controlled Release Pharmaceutical Dosage Forms
Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis with Shorter Durations of Imiquimod Therapy
Methods of Treating Hepatic Encephalopathy
Forms of Rifaximin and Uses Thereof
Tissue Treatment Apparatus with Functional Mechanical Stimulation and Methods for Reducing Pain During Tissue Treatments
New Forms of Rifaximin and Uses Thereof
Medicinal Implant Device and Cartridge
Forms of Rifaximin and Uses Thereof
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Topical Pharmaceutical Foam Composition
Formulations of Rifaximin and Uses Thereof
Method for Preparing a Rifaximin Product
Forms of Rifaximin and Uses Thereof
Rifaximin Derivative and Uses Thereof
High Oil-Content Emollient Aerosol Foam Compositions
Tissue Treatment Apparatus and Systems with Pain Mitigation and Methods for Mitigating Pain During Tissue Treatments
Anti-VLA1 (CD49A) Antibody Pharmaceutical Compositions
Controlled-Release Solid Dosage Forms of Mesalamine
Power Assisted Lipoplasty
Forms of Rifaximin and Uses Thereof
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Methods of Treating Hepatic Encephalopathy
Pump Systems and Methods for Storing and Dispensing a Plurality of Precisely Measured Unit-Doses of Imiquimod Cream
Rifaximin Derivative and Uses Thereof
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Rifaximin Derivative and Uses Thereof
2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTING KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMOD
Methods of Treating Hepatic Encephalopathy
Ibs Microbiota and Uses Thereof
Methods for Treating Irritable Bowel Syndrome (Ibs)
Methods of Treating Hepatic Encephalopathy
Methods of Treating Hepatic Encephalopathy
Methods for Treating Irritable Bowel Syndrome (Ibs)
Methods of Treating Hepatic Encephalopathy
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Controlled-Release Solid Dosage Forms of Mesalamine
2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMOD
Tissue Treatment Apparatus and Systems with Pain Mitigation and Methods for Mitigating Pain During Tissue Treatments
Lower Dosage Strength Imiquimod Formulations and Short Dosing Regimens for Treating Genital and Perianal Warts
Solid Dispersion Forms of Rifaximin
Methods of Treating Hepatic Encephalopathy
Methods for Treating Irritable Bowel Syndrome (Ibs)
Handpiece for a Dermatological Optical Delivery System
Patent:
640,373 →
Application:
29/305,889 →
Ultrasonic Amplifier
Patent:
669,992 →
Application:
29/362,163 →
Console for Use in Power Assisted Lipoplasty
Patent:
669,993 →
Application:
29/375,932 →
Handpiece for Use in Power Assisted Lipoplasty
Patent:
674,479 →
Application:
29/375,936 →
Handpiece
Patent:
680,640 →
Application:
29/402,984 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Merger
May 12, 2021
From: RELIANT TECHNOLOGIES, INC.
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 056218/0067 →
Change of Name
May 12, 2021
From: MEDICIS TECHNOLOGIES CORPORATION
To: LIPOSONIX, INC.
Reel/Frame 056228/0375 →
Merger
May 13, 2021
From: THERMAGE, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056230/0539 →
Merger
May 13, 2021
From: AESTHERA; LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056227/0174 →
Merger
May 14, 2021
From: RELIANT TECHNOLOGIES, LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056244/0936 →
Merger
May 17, 2021
From: LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056257/0362 →
Security Interest
Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Agreement
Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Security Interest
Mar 14, 2022
From: EPI HEALTH, LLC
To: EVENING POST GROUP, LLC
Reel/Frame 059364/0509 →
Security Interest
Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Release of Security Interest
Jan 11, 2023
From: EVENING POST GROUP, LLC
To: EPI HEALTH, LLC
Reel/Frame 062347/0129 →
Intellectual Property Security Agreement
Jun 9, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 063942/0001 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Change of Name
May 12, 2025
From: VALEANT PHARMACEUTICALS NORTH AMERICA LLC
To: BAUSCH HEALTH US, LLC
Reel/Frame 071270/0752 →
Change of Name
May 12, 2025
From: VALEANT PHARMACEUTICALS NORTH AMERICA
To: VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Reel/Frame 071271/0266 →
U.S. Patent Security Agreement
Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073654/0242 →